Lung cancer remains the leading cause of cancer-related mortality worldwide. Early detection of pulmonary nodules is crucial for timely diagnosis and effective treatment.

Several potentially practice-changing phase 3 trials alongside promising results in emerging strategies in chronic lymphocytic leukemia (CLL) presented at the 2025 American Society of Hematology ...

In " Beyond Diagnosis: CLL," Cleveland Clinic hematologist/oncologist Allison Winter, MD, and host John Mangels explore how ...

In this video, we explain vectors and derivatives as essential math methods used in physics, showing how they describe motion, direction, and change. Clear explanations and examples help connect ...

In "Beyond Diagnosis: CLL," Cleveland Clinic hematologist/oncologist Allison Winter, MD, and host John Mangels explore how clinicians can communicate effectively and ...

Tatiana Schlossberg, President John F. Kennedy's granddaughter and Caroline Kennedy's daughter, has died at 35, shortly after revealing a terminal cancer diagnosis of acute myeloid leukemia. In a ...

This is read by an automated voice. Please report any issues or inconsistencies here. “Method dressing often becomes prologue to the film itself — it sets the tone and the context of the film and ...

You can always count on social media to churn out another hack promising health results like you’ve never seen before. The 90-30-50 diet making the rounds on TikTok is no exception. Unlike diets that ...

In the world of oncology drug development, the standard playbook is simple: Race to earlier lines of treatment, where patient populations are larger. But Eli Lilly is flipping that script with its ...

Treatment of chronic lymphocytic leukemia (CLL) currently consists of two main approaches — continuous therapy with Bruton’s tyrosine kinase inhibitors and fixed-duration regimens combining venetoclax ...

Please provide your email address to receive an email when new articles are posted on . Adding ianalumab to ibrutinib allowed many patients with CLL to stop daily ibrutinib for 1 to 2 years. More than ...